West Nile Neuroinvasive Disease Treated With High-Dose Corticosteroids

Cureus. 2022 Nov 28;14(11):e31971. doi: 10.7759/cureus.31971. eCollection 2022 Nov.

Abstract

West Nile neuroinvasive disease, which includes encephalitis, meningitis, or acute flaccid paralysis, is one of the two most common manifestations of West Nile virus (WNV). According to many national agencies, since 1999, WNV has been one of the most common causes of epidemic viral encephalitis in the United States, especially in the state of California, and it will likely remain an important cause of neurological disease for years to come. To date, the mainstay of treatment for West Nile neuroinvasive disease has been supportive care with no data to support the routine use of any agents. Here, we present a unique case of West Nile encephalitis in a 61-year-old male who was successfully treated with a five-day course of high-dose corticosteroids. Although this rapid improvement could be a mere coincidence, it facilitates the need for further trials to determine if high-dose corticosteroids and other drugs may benefit patients in the treatment of West Nile neuroinvasive disease.

Keywords: encephalitis; high-dose corticosteroids; neuroinvasive west nile virus; west nile; west nile virus infection.

Publication types

  • Case Reports